Corvus Pharmaceuticals CRVS Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: Corvus Pharmaceuticals’s 10-K, filed March 25, 2025, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's preferred stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's preferred stock?
- Corvus Pharmaceuticals (CRVS) reported preferred stock of $0 in Q4 2024.
- What does preferred stock mean?
- Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.